Investing Profile

Sander Slootweg

InvestorVC
Co-owner and Managing Partner at Forbion
forbion.comNetherlands
Photo of Sander Slootweg, Managing Partner at Forbion

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
ABN AMRO Bank N.V. Network
35 CONNECTIONS
VU University Amsterdam Network
29 CONNECTIONS
Forbion Network
15 CONNECTIONS
Nyenrode Business University Network
11 CONNECTIONS
cb
Forbion Managing Partner
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
Azafaros
Series BMay 2025$150M
Series AFeb 2020$27M
$180M
Co-investors: Edward Van Wezel (BGV (BioGeneration Ventures))
NorthSea Therapeutics
Series CDec 2021$80M
Series BJan 2020$40M
Series ADec 2017$29M
$150M
Co-investors: Oscar Slotboom (BGV (BioGeneration Ventures)), Rob de Ree (Hotmail), Marco Boorsma (Forbion), Dirk Kersten (Forbion)
New Amsterdam Pharma
Series AJan 2021$190M
$190M
Co-investors: Peter Thiel (Founders Fund), Gaurav Gupta (Ascendant BioCapital)
Oxyrane UK
Series DNov 2011$27M
$27M
Director ABN AMRO Bank N.V.Present
Co-owner and Managing Partner ForbionPresent
Nyenrode Business University BBA Business
VU University Amsterdam MSc Economics/Finance